gtbiopharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title GT Biopharma, Inc.
Description --> Nasdaq: GTBP Home About Management Team Our Technologies Publications Product Pipeline Overview Corporate Presentation News & Media Press Releases
Keywords N/A
Server Information
WebSite gtbiopharma favicongtbiopharma.com
Host IP 174.129.30.187
Location United States
Related Websites
Site Rank
More to Explore
gtbiopharma.com Valuation
US$13,327,587
Last updated: 2023-04-29 03:46:01

gtbiopharma.com has Semrush global rank of 794,165. gtbiopharma.com has an estimated worth of US$ 13,327,587, based on its estimated Ads revenue. gtbiopharma.com receives approximately 1,537,799 unique visitors each day. Its web server is located in United States, with IP address 174.129.30.187. According to SiteAdvisor, gtbiopharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$13,327,587
Daily Ads Revenue US$12,303
Monthly Ads Revenue US$369,072
Yearly Ads Revenue US$4,428,860
Daily Unique Visitors 102,520
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
gtbiopharma.com. A 599 IP: 174.129.30.187
gtbiopharma.com. A 599 IP: 54.208.101.55
gtbiopharma.com. NS 3600 NS Record: ns29.domaincontrol.com.
gtbiopharma.com. NS 3600 NS Record: ns30.domaincontrol.com.
gtbiopharma.com. MX 3600 MX Record: 0 gtbiopharma-com.mail.protection.outlook.com.
gtbiopharma.com. TXT 1800 TXT Record: facebook-domain-verification=458qfmzq4gngidtrayr59cb7waq4b4
gtbiopharma.com. TXT 1800 TXT Record: v=spf1 include:spf.protection.outlook.com -all
gtbiopharma.com. TXT 1800 TXT Record: google-site-verification=U2wKyoAndzCIRsUK6pb5MzbKDvTYSeFLeyMRVL9ah0c
gtbiopharma.com. TXT 1800 TXT Record: google-site-verification=OHnqG3OwrZ5H4h-k-o6OQNS-SppDXWqCaFfN7r6m97c
HtmlToTextCheckTime:2023-04-29 03:46:01
--> Nasdaq: GTBP Home About Management Team Our Technologies Publications Product Pipeline Overview Corporate Presentation News & Media Press Releases Presentations Investors Investors Overview News / Events Press Releases IR Calendar Email Alerts Company Info Profile Presentations Management Team Financial Info Financials Financial Results Stock Data Quote Charts Historical Data SEC Filings All SEC Filings Annual Reports Quarterly Reports Section 16 Filings Form 8937 Form 8937 Governance Board of Directors Governance Documents Board Diversity Matrix Contact Careers Shareholder letter... GT BIOPHARMA ISSUES OPEN LETTER TO SHAREHOLDERS DETAILING RECENT ACTIVITIES Immunotherapy for the Treatment of Cancer Using our proprietary platform technology, GT Biopharma is generating novel immuno-oncology biopharmaceutical drugs targeting cancers such as acute lymphocytic leukemia, non-Hodgkin’s lymphoma, acute myeloid leukemia and multiple solid tumors. View Product Pipeline About GT
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Fri, 22 Oct 2021 00:51:29 GMT
Server: Apache
Location: http://www.gtbiopharma.com/
Content-Type: text/html; charset=UTF-8

HTTP/1.1 302 Moved Temporarily
Content-Type: text/html; charset=UTF-8
Date: Fri, 22 Oct 2021 00:51:30 GMT
Location: https://www.gtbiopharma.com/
Server: Apache
Connection: keep-alive

HTTP/1.1 200 OK
Date: Fri, 22 Oct 2021 00:51:30 GMT
Server: Apache
Content-Type: text/html; charset=UTF-8
gtbiopharma.com Whois Information
Domain Name: GTBIOPHARMA.COM
Registry Domain ID: 2133828491_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-06-15T18:45:29Z
Creation Date: 2017-06-14T19:31:33Z
Registry Expiry Date: 2022-06-14T19:31:33Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS29.DOMAINCONTROL.COM
Name Server: NS30.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-10T19:36:47Z <<<